Liberia: LCM Takes TB/HIV Dialogue to Southeastern Liberia
[FrontPageAfrica] Monrovia -The Liberia Coordinating Mechanism (LCM) of the Global Fund to fight AIDS, TB and Malaria have completed a two-day Country Dialogue for Region 5 counties to provide input to the development of a new joint national TB/HIV funding request for the country. River Gee, Maryland and Grand Kru which are in southeastern Liberia were grouped as region 5 counties to prioritize areas of intervention for the development of a joint TB/HIV funding request for submission to the Global Fund.
February 14, 2020 Chapel Hill, NCToday, IntraHealth International’s board of directors announced Polly Dunford will be IntraHealth’s next president and CEO. She will assume the role on March 16.Dunford is joining IntraHealth after nearly 20 years of service with the US Agency for International Development (USAID) in Cambodia, Haiti, Jordan, Mozambique, Nigeria and Washington, D.C., most recently as the global director for HIV/AIDS. In this role, she led the agency’s efforts to help countries achieve and sustain epidemic control of HIV/AIDS under the President’s Emergency Plan for AIDS Relief ...
[ANGOP] Luanda -The chairperson of the Global Fund, Donald Kaberuka, reaffirmed this Monday, in Luanda, his support to the Angolan Government, with the aim of eradicating diseases such as malaria, tuberculosis and HIV / AIDS, by 2030.
ConclusionsThe year 2020 will be crucial for the future of the global response to NTDs. Progress against the 2020 roadmap targets will be assessed, a new 2021 –2030 NTD roadmap will be launched, and the London Declaration commitments will need to be renewed. It is hoped that during the coming decade the global response will be able to further build on today’s successes, align with the new global health and development frameworks, but also keep focused attention on NTDs and mobilize enough resources to see the effort effectively through to 2030.
Coendemicity between the human immunodeficiency virus (HIV) and Plasmodium parasites, the causative agents of acquired immunodeficiency syndrome (AIDS) and malaria, respectively, occurs in several regions around the world. Although the impact of the interaction between these two organisms is not well understood, it is thought that the outcome of either disease may be negatively influenced by coinfection. Therefore, it is important to understand how current first-line antiretroviral therapies (ART) might impact Plasmodium infection in these regions. Here, we describe the effect of 18 antiretroviral compounds and of first-li...
[AIM] Maputo -Mozambique's Coordination Mechanism for the Global Fund to Fight AIDS, Tuberculosis and Malaria on Wednesday reached consensus on the need to create strong and resilient health systems that can respond effectively to the challenges of the Sustainable Development Goals (SDGs).
[Daily News] MANY developing countries have been struggling to control malaria, HIV, and maternal mortality, but for Zanzibar the progress is arguably encouraging.
[Nation] The Global Fund -- the agency that helps Kenya fight HIV/Aids, tuberculosis and malaria -- has given the country Sh42 billion to be used up to 2024.
[FrontPageAfrica] Bomi County -The Liberia Coordinating Mechanism (LCM) of the Global Fund (TGF) to fight AIDS, TB and Malaria has commenced a regional consultative prioritization country dialogue to develop a joint funding request for Tuberculosis and HIV, on behalf of the country, for submission to the Fund.
[New Dawn] The Liberia Coordinating Mechanism (LCM) of the Global Fund (TGF) to fight AIDS, TB and Malaria has commenced a regional consultative prioritization country dialogue to develop a joint funding request for Tuberculosis and HIV, on behalf of the country, for submission to the Fund.
Conclusion: The share of development assistance invested in the CHW projects was small, unstable and decreasing in recent years. More research is needed on tracking government investments in CHW-related projects and assessing the impact of investments on programme effectiveness. PMID: 31902960 [PubMed - in process]